"Altria reported Q1 2026 recently, delivering adjusted diluted EPS of $1.32 versus the $1.24 consensus, a 5.92% beat and the fourth consecutive quarter topping estimates. Revenue of $5.43 billion grew 20.1% YoY, helped by 610 million contract-manufactured export sticks."
"The bull case rests on premium pricing power and the smoke-free pivot. Marlboro held a 59.5% share of the premium segment, on! shipment volume rose 17.6%, and U.S. nicotine pouches now command 58.1% of oral tobacco."
"Domestic cigarette industry volume fell roughly 5% in Q1, Marlboro retail share slipped 1.4 points to 39.7%, and on! lost 4.2 points of category share."
Altria's stock has rebounded from a low of $58.19 to $72.65, achieving a 28.09% gain year-to-date. The company reported Q1 2026 earnings with adjusted diluted EPS of $1.32, surpassing the consensus of $1.24. Revenue increased by 20.1% year-over-year to $5.43 billion. The stock is near its 52-week high of $73.85. The bull case suggests potential for further growth due to premium pricing power and a shift towards smoke-free products, while risks include declining cigarette volume and market share.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]